These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Spatial relationship of AMY protein deposits and different species of Abeta peptides in amyloid plaques of the Alzheimer disease brain. Schmidt ML; Saido TC; Lee VM; Trojanowski JQ J Neuropathol Exp Neurol; 1999 Dec; 58(12):1227-33. PubMed ID: 10604747 [TBL] [Abstract][Full Text] [Related]
13. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains. Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307 [TBL] [Abstract][Full Text] [Related]
14. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. Cho HS; Hyman BT; Greenberg SM; Rebeck GW J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ. Meilandt WJ; Maloney JA; Imperio J; Lalehzadeh G; Earr T; Crowell S; Bainbridge TW; Lu Y; Ernst JA; Fuji RN; Atwal JK Alzheimers Res Ther; 2019 Dec; 11(1):97. PubMed ID: 31787113 [TBL] [Abstract][Full Text] [Related]
16. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains. Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613 [TBL] [Abstract][Full Text] [Related]
18. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain. Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models. Kumar S; Lemere CA; Walter J Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580 [TBL] [Abstract][Full Text] [Related]
20. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]